Drug Profile
COL 179
Alternative Names: COL-179Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Onset Therapeutics
- Developer Onset Dermatologics
- Class Anti-inflammatories; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Skin disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Skin-disorders in USA (Topical, Foam)
- 11 Jun 2010 Clinical trials in Skin disorders in USA (Topical)